PIONEERING NANO-BIOTECHNOLOGY COMPANY. WITH OVER 20 YEARS RESEARCHING AND DEVELOPING OUR PATENT-PENDING NANOSPHERE DELIVERY SYSTEM™.
PATENTED NANOSPHERE DELIVERY TECHNOLOGY™ INCREASES THE BIOAVAILABILITY AND BIOACTIVITY OF CANNABINOIDS.
NANOSPHERE HEALTH IS THE FIRST AND ONLY COMPANY TO NANO-SIZE AND ENCAPSULATE CANNABINOIDS, DRAMATICALLY CHANGING THE INDUSTRY.
266
Q& A
PRODUCT OVERVIEW
NanoSphere’s initial product deployment is for the cannabinoid market, targeting both the medical marijuana market and, where legalized, the recreational usage market. NanoSphere has already partnered with a licensee in Colorado, and has launched its first award-winning cannabinoid product line, branded Evolve NanoSerum™, in the Colorado market. NanoSphere will further license its intellectual property and proprietary manufacturing method to selected cannabis cultivators, extractors and distributors on a state-by-state basis and abroad, and is currently in discussions with operators in several states to replicate the business model in Colorado. Other planned future deployments include nutraceuticals, non steroidal anti-inflammatory drugs and animal health applications.
CI: What is the importance of testing and how does research benefit cannabis consumers?
NSHSF: Current products on the market make precise dosage unclear. Everybody is different and metabolizes cannabinoids in different ways. Yet for the most part, this is not clearly communicated to the consumer. Through testing, the exact number and concentration of cannabinoids in each product is understood, making the user better educated about the specific effects, thereby leading to a safer, more controlled experience. Additionally, marijuana is a plant. With that, comes fungus, pesticide residue and other parasites that grow in the ground. Of course, most organizations clean the plant thoroughly before heading into the product development stage, but often, that’s not enough. There should be scientific testing and research at every level to ensure safety and quality, not just a quick rinse. In the pharmaceutical industry, biotechnology firms put in years of research before a new medication hits the market. Why not the same standard for the marijuana industry?
Our strategy is to be a world-leading nanoparticle delivery company; and research, development and testing is vital to true innovation. We have assembled an extensive team to help facilitate all aspects of product development. We are also unique in the fact that we are the only company in the industry conducting human blood pharmacokinetic studies with an independent third-party laboratory, confirming our products have measurable THC blood concentrations within 10 minutes.
CI: Could you explain the importance of NanoSphere Health Sciences awarded patent for Disruptive Nanoparticle Delivery Platform?
OTC: NSHSF ; CSE: NSHS